Data as of Nov 21
| +0.16 / +2.03%|
The 5 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 19.00, with a high estimate of 40.00 and a low estimate of 16.00. The median estimate represents a +136.02% increase from the last price of 8.05.
The current consensus among 5 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.